Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Reusser

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
The Journal of Antibiotics|November 1, 1983
Fermentation, isolation, characterization and structure of nitrosofunginL A Dolak, T M Castle, B R Hannon, et al.
The Journal of Antibiotics|January 1, 1983
Desertomycin: purification and physical-chemical propertiesL A Dolak, F Reusser, L Baczynskyj, et al.
The Journal of Antibiotics|October 1, 1976
Antibiotics produced by Streptomyces ficellus. I. FicellomycinA D Argoudelis, F Reusser, H A Whaley, et al.
Journal of the American Chemical Society|January 17, 1976
Letter: Berninamycin. I. The structure of berninamycinic acidJ M Liesch, J A McMillan, R C Pandey, et al.
Biochemistry|February 26, 1974
Relative biological activities of individual streptovaricins and streptovaricin acetatesK L Rinehart, F J Antosz, K Sasaki, et al.
Journal of Medicinal Chemistry|May 14, 1993
Bis(heteroaryl)piperazine (BHAP) reverse transcriptase inhibitors: structure-activity relationships of novel substituted indole analogues and the identification of 1-[(5-methanesulfonamido-1H-indol-2-yl)-carbonyl]-4-[3- [(1-methylethyl)amino]-pyridinyl]piperazine monomethanesulfonate (U-90152S), a second-generation clinical candidateD L Romero, R A Morge, M J Genin, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1993
U-90152, a potent inhibitor of human immunodeficiency virus type 1 replicationT J Dueweke, S M Poppe, D L Romero, et al.
The Journal of Antibiotics|February 1, 1976
Identification and preparation of damavaricins, biologically active precursors of streptovaricinsK L Rinehart, F J Antosz, P V Deshmukh, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1991
Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replicationD L Romero, M Busso, C K Tan, et al.
Experientia|December 1, 1992
Enzymatic kinetic studies with the non-nucleoside HIV reverse transcriptase inhibitor U-9843I W Althaus, R J LeMay, A J Gonzales, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
The Journal of Antibiotics|November 1, 1983
Fermentation, isolation, characterization and structure of nitrosofunginL A Dolak, T M Castle, B R Hannon, et al.
The Journal of Antibiotics|January 1, 1983
Desertomycin: purification and physical-chemical propertiesL A Dolak, F Reusser, L Baczynskyj, et al.
The Journal of Antibiotics|October 1, 1976
Antibiotics produced by Streptomyces ficellus. I. FicellomycinA D Argoudelis, F Reusser, H A Whaley, et al.
Journal of the American Chemical Society|January 17, 1976
Letter: Berninamycin. I. The structure of berninamycinic acidJ M Liesch, J A McMillan, R C Pandey, et al.
Biochemistry|February 26, 1974
Relative biological activities of individual streptovaricins and streptovaricin acetatesK L Rinehart, F J Antosz, K Sasaki, et al.
Journal of Medicinal Chemistry|May 14, 1993
Bis(heteroaryl)piperazine (BHAP) reverse transcriptase inhibitors: structure-activity relationships of novel substituted indole analogues and the identification of 1-[(5-methanesulfonamido-1H-indol-2-yl)-carbonyl]-4-[3- [(1-methylethyl)amino]-pyridinyl]piperazine monomethanesulfonate (U-90152S), a second-generation clinical candidateD L Romero, R A Morge, M J Genin, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1993
U-90152, a potent inhibitor of human immunodeficiency virus type 1 replicationT J Dueweke, S M Poppe, D L Romero, et al.
The Journal of Antibiotics|February 1, 1976
Identification and preparation of damavaricins, biologically active precursors of streptovaricinsK L Rinehart, F J Antosz, P V Deshmukh, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1991
Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replicationD L Romero, M Busso, C K Tan, et al.
Experientia|December 1, 1992
Enzymatic kinetic studies with the non-nucleoside HIV reverse transcriptase inhibitor U-9843I W Althaus, R J LeMay, A J Gonzales, et al.
Pageof 5